ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,141Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 335

$872K Total Retail Price of All Prescriptions

Rank: 6 out of 335

855 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 855 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

14% of this provider’s 855 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 14,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SOTALOL 1,030 946 10 1 24
ISOSORBIDE MONONITRATE ER 793 740 2 10
AMLODIPINE BESYLATE 614 587 3 5
SIMVASTATIN 514 472 4 4
CLOPIDOGREL 510 482 5 7
OMEPRAZOLE 494 446 6 29
HYDROCODONE-ACETAMINOPHEN 479 372 S3 7 55
LEVOTHYROXINE SODIUM 390 352 8 36
PLAVIX 376 354 9 12
FUROSEMIDE 329 286 10 6
VERAPAMIL ER 318 285 11 61
LOSARTAN POTASSIUM 286 227 12 16
LISINOPRIL 283 237 13 2
LOVASTATIN 275 260 14 49
PRAVASTATIN SODIUM 254 232 15 13
WARFARIN SODIUM 249 197 16 8
TRAMADOL HCL 246 212 17 82
METOPROLOL TARTRATE 238 207 18 3
METOPROLOL SUCCINATE 237 200 19 9
CLONIDINE HCL 237 205 19 33
POTASSIUM CHLORIDE 232 204 21 18
DOXAZOSIN MESYLATE 206 199 22 57
AMIODARONE HCL 183 151 23 21
FENOFIBRATE 176 156 24 47
ZOLPIDEM TARTRATE 175 126 25 69
TRIAMTERENE-HCTZ 172 139 26 46
ATENOLOL 169 148 27 15
LABETALOL HCL 161 122 28 77
GABAPENTIN 158 147 29 71
BENAZEPRIL HCL 154 147 30 30
MELOXICAM 154 144 30 89
METFORMIN HCL 144 124 32 67
PROPAFENONE HCL 131 121 33 50
NEXIUM 114 83 34 72
ATORVASTATIN CALCIUM 112 97 35 11
PREDNISONE 109 105 36 100
SUCRALFATE 108 96 37 147
DIOVAN 106 79 38 28
NITROSTAT 99 95 39 22
AMITRIPTYLINE HCL 96 82 R 40 106
TAMSULOSIN HCL 95 94 41 79
CRESTOR 94 85 42 17
CARVEDILOL 90 75 43 1
DIOVAN HCT 90 81 43 81
KLOR-CON M20 89 80 45 39
ALLOPURINOL 88 82 46 68
TERAZOSIN HCL 84 84 47 73
SPIRONOLACTONE 80 74 48 20
NIFEDIPINE ER 79 79 49 59
SINGULAIR 78 73 50 108
DIPYRIDAMOLE 77 71 R 51 159
SERTRALINE HCL 76 67 52 92
SYNTHROID 76 74 52 160
LEVOFLOXACIN 74 67 54 114
PANTOPRAZOLE SODIUM 72 65 55 48
TICLOPIDINE HCL 71 71 R 10 56 167
PENTOXIFYLLINE 69 69 57 110
NADOLOL 65 50 58 99
PREMARIN 63 63 R 59 175
CITALOPRAM HBR 60 55 60 75
ZETIA 60 59 60 34
ADVAIR DISKUS 59 39 62 180
CYMBALTA 57 43 63 140
THEOPHYLLINE ANHYDROUS 56 56 64 186
FINASTERIDE 56 56 64 111
GLIMEPIRIDE 53 35 66 97
CILOSTAZOL 50 41 67 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.